1 in 3 people in the US are Hypertensive, join us to reverse this trend!

1 in 3 people in the US are Hypertensive, join us to reverse this trend!

  • Welcome!

    Posted on by admin


    Welcome to the Delaware Valley Chapter of the American Society of Hypertension (ASHDV).  If visiting, we hope you find it informative and consider membership. Membership information can be obtained on the following page.  Please do not forget to check off the regional ASH-DV membership when applying.  If a member, we hope you find website’s contents thought provoking.  The website is growing actively and we are sincere in our interest in hearing feedback and looking for active and involved members.  A case will be presented regularly on the website under Case Presentation.  Comments will be moderated prior to publication.

    Please feel free to explore the website and comment on the cases.  Finally, abstracts submitted at the annual ASHDV October meeting are also available to review on the website.

    ASHDV is a chapter member of the American Society of Hypertension (ASH), which is the largest US organization dedicated exclusively to hypertension. ASH was founded in 1985 with a mission “to translate and promote current research in hypertension and vascular disease into effective treatment strategies for patients with hypertension and associated disorders.” The Society continues to fulfill its mission by holding annual meetings, publishing multiple journals, publishing position papers in the field of hypertension, community outreach and promoting and disseminating research related to blood pressure.  A major undertaking of ASH is the development of the Specialists in Clinical Hypertension program.  The ASH Specialist in Clinical Hypertension identifies and recognizes physicians with expert skills and knowledge in the management of clinical hypertension and related disorders. These physicians can act as local and regional consultants for the more complex and difficult cases and also assist in advice regarding guidelines and process improvement. To date, designation has been granted to 1419 physicians practicing in the United States, Canada and other countries.

    Membership of ASH is open to all those who have undertaken and accomplished meritorious original scientific investigation in the field of hypertension and/or related cardiovascular disease, those involved in the diagnosis and treatment of hypertension and related cardiovascular disease, and those with a demonstrated serious interest in the field. Among the benefits of ASH membership are association and interaction with clinicians and scientists who are world leaders in the field, a listing in the ASH Member Directory used for patient referral, and savings on registration fees for the annual scientific meeting.

    The Delaware Valley Chapter of the American Society of Hypertension comprises a regional group of health care workers interested in hypertension.  This includes physicians, nurses, CRNPs, PAs, MAs, pharmacists, administrators, and members of the pharmaceutical industry.  A major focus of the Chapter is education and community outreach.  An annual conference is held each October in Philadelphia in order to summarize developments from the national ASH meeting, provide ongoing education in the field of hypertension, and provide a forum for discussion of regional research and patient care projects with a focus on hypertension.  CME accreditation has been available.

    Once again, welcome to our organization.  We hope you find enjoy it and consider membership in the American Society of Hypertension and ASHDV.

    Christopher McFadden, MD

    President, ASHDV

    2014 Hypertension Guidelines now available.

    2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults:  Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) FREE

    Paul A. James, MD1; Suzanne Oparil, MD2; Barry L. Carter, PharmD1; William C. Cushman, MD3; Cheryl Dennison-Himmelfarb, RN, ANP, PhD4; Joel Handler, MD5; Daniel T. Lackland, DrPH6; Michael L. LeFevre, MD, MSPH7; Thomas D. MacKenzie, MD, MSPH8; Olugbenga Ogedegbe, MD, MPH, MS9; Sidney C. Smith Jr, MD10; Laura P. Svetkey, MD, MHS11; Sandra J. Taler, MD12; Raymond R. Townsend, MD13; Jackson T. Wright Jr, MD, PhD14; Andrew S. Narva, MD15; Eduardo Ortiz, MD, MPH16,17

    [+-] Author Affiliations

    1University of Iowa, Iowa City
    2University of Alabama at Birmingham School of Medicine
    3Memphis Veterans Affairs Medical Center and the University of Tennessee, Memphis
    4Johns Hopkins University School of Nursing, Baltimore, Maryland
    5Kaiser Permanente, Anaheim, California
    6Medical University of South Carolina, Charleston
    7University of Missouri, Columbia
    8Denver Health and Hospital Authority and the University of Colorado School of Medicine, Denver
    9New York University School of Medicine, New York, New York
    10University of North Carolina at Chapel Hill
    11Duke University, Durham, North Carolina
    12Mayo Clinic College of Medicine, Rochester, Minnesota
    13University of Pennsylvania, Philadelphia
    14Case Western Reserve University, Cleveland, Ohio
    15National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland
    16at the time of the project,National Heart, Lung, and Blood Institute, Bethesda, Maryland
    17currently with ProVation Medical, Wolters Kluwer Health, Minneapolis, Minnesota

    JAMA. 2014;311(5):507-520. doi:10.1001/jama.2013.284427.


©2015 ASHDV Entries (RSS) and Comments (RSS)  Raindrops Theme